Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
The Evolving Toolbox for Treating Difficult Warts
Description
Dr. Peter Friedman discusses the complexities of treating difficult warts in dermatology at a recent conference. He emphasizes the significant impact warts can have on mental health and quality of life, citing various patient cases, including those affected by aesthetics and job performance. The presentation highlights the limitations of traditional treatments like salicylic acid and cryotherapy, which often exhibit low efficacy and high recurrence rates. Dr. Friedman suggests intralesional immunotherapy, such as Candida and PPD, as effective options, especially for recalcitrant warts, while also updating on newer methods such as microneedling combined with topical agents. He advocates for personalized treatment approaches, considering factors like patient tolerance, potential side effects, and healthcare costs. Innovative therapies like intralesional adherence to antivirals, nitric oxide agents, and atmospheric physical plasma are also explored as potential future treatments. Dr. Friedman stresses the importance of utilizing a diverse treatment toolbox tailored to individual patient needs, emphasizing that comprehensive care can lead to improved outcomes and patient satisfaction.
View moreConclusions
- Warts have significant aesthetic and functional impacts on individuals, necessitating effective treatments.
- Existing treatments for warts such as salicylic acid and cryotherapy have limited efficacy and can vary in effectiveness among patients.
- Difficult-to-treat warts often feature characteristics like duration, size, number of lesions, and location in medically or cosmetically problematic areas.
- Intralesional immunotherapy using various antigens can induce immune responses that help clear warts, sometimes with collateral distant effects.
- Newer treatments, including intralesional vaccines and antiviral therapies, show promise but require further study for standardized use.
- Microneedling combined with topical agents such as 5-FU enhances treatment efficacy, providing a practical approach for large areas or multiple lesions.
- Emerging therapies such as nitric oxide and plasma treatments present novel avenues for wart management and demonstrate good patient tolerance.
- Tailoring treatment approaches based on individual patient circumstances and wart characteristics may lead to improved outcomes and satisfaction.
- Ghorzang et al. JEADV 2022
- Artese et al. 1994
- Nofal et al. Dermatology Therapy 2022;35(6):1-6
- Nofal et al. JAAD 2019
- Attwa et al. J Derm Tr 2020
- Ibrahim et al. Derm Th 2019
- Salman et al. JAAD 2022
- Copling, Lesley JAAD Case Reports 2023; 39:142-144
- Ju et al. Indian J Dermatol Venereol Leprol 2022
- Ahn et al. Am J Clin Dermatol 2014
- Ghonemy et al. Dermatologic Therapy 2020;50(6):776-780
- Vatankhah et al. Arch Derm Res. 2024
- Espana et al. JEADV 2016;30(7),11218-1220
- Moore, Kovarik JAAD 2015;73:e23-24
- Broganelli et al. Derm Therapy 2012
- Anshelevich et al. JAAD 2020
- Poppens et al. J Derm Treatment 2023
- Elsayed et al. J Cut Med Surg 2022
- Reddy et al. Cureus 2023
- Mohta. Clin Exp Dermatol 2022
- Wu et al. JAMA Derm 2022